why is compounded tirzepatide banned Troubling Findings in Study of GLP-1 Compounders The U.S. Food and Drug

Human research is somewhat limited and mixed, with outcomes likely depending on dosage, duration, age, training status, and inflammatory state To view or add a comment, sign in For many autoimmune patients, the journey to finding the right medication is long

Side effect limited responders The medication might have worked if you could have tolerated it

With fast appointments available, most patients are seen within 24 hours, ensuring no waitlists keep you from starting your weight loss journey

Weight Outcomes After 1 year of follow-up with continuous treatment, the mean (SD) weight was 89.9 (22.4) kg in the semaglutide 2.4 mg cohort and 87.6 (22.6) kg in the tirzepatide cohort (Table 3)

The desire for independence from medication motivates many decisions

Published Research on AOD-9604 The following peer-reviewed studies are summarized below